Clinical Trials Logo

Cesarean Wound clinical trials

View clinical trials related to Cesarean Wound.

Filter by:
  • None
  • Page 1

NCT ID: NCT04211597 Completed - Clinical trials for Scar; Previous Cesarean Section, Complicating Pregnancy or Childbirth, Affecting Fetus or Newborn

EGF-loaded Chitosan to Facilitate Healing and Prevent Scar Formation of Cesarean Wound

Start date: September 5, 2017
Phase: N/A
Study type: Interventional

Cesarean section (CS) is a major surgical intervention that affects women at childbearing age. Scarring from CS potentially causes discomfort and psychological distress. Emerging evidence indicates that epidermal growth factor (EGF) plays crucial roles in wound healing with the potential of minimizing scar formation. This study aims to investigate the effect of microencapsulated recombinant human EGF (Me-EGF) in scar prevention. Silicone gel was incorporated as part of the routine scar treatment. Healthy women scheduled for cesarean delivery will be enrolled and randomized to three groups: (1) no scar treatment, (2) silicone gel only, or (3) silicone gel plus Me-EGF. Vancouver Scar Scale (VSS) will be used for scar assessment at the 6th month and 9th month after CS.